DAIC

MARCH 14, 2025

The Transplant Company recently announced that AlloSureis now commercially available for pediatric heart transplant patients of all ages and patients who have received a simultaneous pancreas-kidney (SPK) transplant. 1 "The availability of AlloSure dd-cfDNA for all pediatric heart transplant patients is a major development.

Heart Transplant 87

Heart Transplant Transplant Pediatrics Quality of Life 87

DAIC

FEBRUARY 13, 2024

Pictured Left to Right: Members and students of the McGill Gene Editing Laboratory at The Texas Heart Institute in Houston, Texas: Fansen Meng, PhD, Xiao Li, PhD, James Martin, MD, PhD, Rich Li, PhD (back), Maggie Lim (undergraduate student at Rice University front), Yuka Morikawa, PhD, Ann Bromley.

Transplant 111

Transplant Pediatrics Heart Transplant Research 111

Frontiers in Cardiovascular Medicine

JANUARY 31, 2024

A comprehensive evaluation of clinical, laboratory, radiographic features, disease activity, treatment and outcomes was carried out. The mean Pediatric Vasculitis Activity Score (PVAS), Takayasu Clinical Activity Score (ITAS-2010) and ITAS-A scores were 2.8/63, All patients had aberrant laboratory parameters. 36) months.

Laboratory 64

Laboratory Pediatrics Hypertension Outcomes 64

Frontiers in Cardiovascular Medicine

FEBRUARY 19, 2024

Methods We performed a retrospective analysis to examine the clinical manifestations, genetic traits, and the relationship between PD and mitochondrial function in a pediatric patient. Laboratory tests and echocardiography confirmed heart failure and hypertrophic cardiomyopathy.

Cardiogenic Shock 59

Cardiogenic Shock Quality of Life Heart Failure Laboratory 59

Circulation

NOVEMBER 6, 2023

Background:Supported by laboratory and clinical investigations of adult cardiopulmonary arrest, resuscitation guidelines recommend monitoring end-tidal carbon dioxide (ETCO2) as an indicator of CPR quality but note that "specific values to guide therapy have not been established in children."Methods:This Circulation, Ahead of Print.

Blood Pressure 40

Blood Pressure Pediatrics Laboratory Hospital 40

Stroke Journal

FEBRUARY 1, 2024

Laboratory data for each vascular event (stroke or TIA) were collected. The most recent laboratory data preceding events were also collected (baseline). Perioperative events (those occurring ≤7 days after revascularization) were excluded.

Laboratory 40

Laboratory Risk Factors Strokes Stroke 40

Circulation

NOVEMBER 11, 2024

To explore an association with MIS-C we investigated the sero-epidemiology of CV in admitted pediatric patients.Method:A retrospective case control study was performed by chart review of children (age ≤ 21) admitted to a tertiary care hospital with CV serological testing from January 2017 to August 2023. of cases respectively.

Laboratory 40

Laboratory Pediatrics Circulation Hospital 40